Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
51 - 94 out of 94Page size: 50
Sort by: 1st author
  1. Published

    Ibrutinib and venetoclax for first-line treatment of CLL

    Kater, A. P., Levin, M. D. & Niemann, Carsten, 2019, In: New England Journal of Medicine. 381, 8, p. 788-789 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  2. Published

    Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation

    Kielbassa, K., Haselager, M. V., Bax, D. J. C., van Driel, B. F., Dubois, J., Levin, M. D., Kersting, S., Svanberg, R., Niemann, Carsten, Kater, A. P. & Eldering, E., 2023, In: Leukemia. 37, 6, p. 1268-1276 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

    Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma

    Klausen, U., Grønne Dahlager Jørgensen, N., Grauslund, J. H., Munir Ahmad, S., Gang, Anne Ortved, Martinenaite, E., Weis-Banke, S. E., Breinholt, M. F., Novotny, G. W., Kjeldsen, J. W., Orebo Holmström, M., Pedersen, L. B., Poulsen, C. B., Hansen, P. B., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2021, In: OncoImmunology. 10, 1, 1975889.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

    Kolstad, A., Pedersen, L. B., Eskelund, C. W., Husby, S., Grønbæk, K., Jerkeman, M., Laurell, A., Räty, R., Elonen, E., Andersen, N. S., Brown, P. D. N., Kimby, E., Bentzen, H., Sundström, C., Ehinger, M., Karjalainen-Lindsberg, M. L., Delabie, J., Ralfkiær, E., Fagerli, U. M., Nilsson-Ehle, H. & 5 others, Lauritzsen, G. F., Kuittinen, O., Niemann, Carsten, Geisler, C. H. & the Nordic Lymphoma Group, T. N. L. G., Mar 2017, In: Biology of Blood and Marrow Transplantation. 23, 3, p. 428-435 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy

    Kyvsgaard, Emil Ramsø, Riley, C., Clausen, M. R., Harsløf, Mads, Heftdal, Line Dam, Niemann, Carsten, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 2024, In: British Journal of Haematology. 204, 1, p. 356-360 5 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  7. Published

    Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma

    Lokhande, L., Kuci Emruli, V., Eskelund, C. W., Kolstad, A., Hutchings, M., Räty, R., Niemann, Carsten, Grønbæk, Kirsten, Jerkeman, M. & Ek, S., 2022, In: Cancer Reports. 5, 8 p., e1524.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia

    Lorenzovici, L., Szilberhorn, L., Farkas-Ráduly, S., Gasparik, A. I., Precup, A. M., Nagy, A. G., Niemann, Carsten, Aittokallio, T., Kaló, Z. & Csanádi, M., 2023, In: BioDrugs. 37, 2, p. 219-233 15 p.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia - Update on methodological approaches and results interpretation

    Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, Carsten, Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P. & Pospisilova, S., 1 May 2018, In: Leukemia. 32, 5, p. 1070-1080

    Research output: Contribution to journal › Review › Research › peer-review

  10. Published

    Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Mansouri, L., Thorvaldsdottir, B., Sutton, L. A., Karakatsoulis, G., Meggendorfer, M., Parker, H., Nadeu, F., Brieghel, C., Laidou, S., Moia, R., Rossi, D., Catherwood, M., Kotaskova, J., Delgado, J., Rodríguez-Vicente, A. E., Benito, R., Rigolin, G. M., Bonfiglio, S., Scarfo, L., Mattsson, M. & 41 others, Davis, Z., Gogia, A., Rani, L., Baliakas, P., Foroughi-Asl, H., Jylhä, C., Skaftason, A., Rapado, I., Miras, F., Martinez-Lopez, J., de la Serna, J., Rivas, J. M. H., Thornton, P., Larráyoz, M. J., Calasanz, M. J., Fésüs, V., Mátrai, Z., Bödör, C., Smedby, K. E., Espinet, B., Puiggros, A., Gupta, R., Bullinger, L., Bosch, F., Tazón-Vega, B., Baran-Marszak, F., Oscier, D., Nguyen-Khac, F., Zenz, T., Terol, M. J., Cuneo, A., Hernández-Sánchez, M., Pospisilova, S., Mills, K., Gaidano, G., Niemann, Carsten, Campo, E., Strefford, J. C., Ghia, P., Stamatopoulos, K. & Rosenquist, R., 2023, In: Leukemia. 37, 2, p. 339-347 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Readmissions, Postdischarge Mortality, and Sustained Recovery Among Patients Admitted to Hospital With Coronavirus Disease 2019 (COVID-19)

    Moestrup, K. S., Reekie, J., Zucco, Adrian G., Jensen, T. Ø., Jensen , Jens-Ulrik Stæhr , Wiese, L., Ostrowski, Sisse Rye, Niemann, Carsten, MacPherson, C. R., Lundgren, Jens & Helleberg, Marie, 8 Feb 2023, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76, 3, p. e82-e89 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study

    Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M. D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, Q., Steele, A., Schuier, N., Baeten, K., Caces, D. B. & 2 others, Niemann, Carsten & Kater, A., 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S264-S265

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  13. Published

    Impact of Minimal Residual Disease on Progression-Free Survival Outcomes after Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study

    Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M. D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, K., Qi, Q., Parisi, L., Srinivasan, S., Schuier, N. & 5 others, Baeten, K., Howes, A., Caces, D. B., Niemann, Carsten & Kater, A. P., 2023, In: Journal of Clinical Oncology. 41, 21, p. 3689-3699 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia

    Niemann, Carsten, Levin, M., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Mattsson, M., Bellido, M., Tran, H. T. T., Nasserinejad, K. & Kater, A. P., 2021, In: Blood. 137, 8, p. 1117-1120

    Research output: Contribution to journal › Letter › Research › peer-review

  15. Published

    COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

    Niemann, Carsten, Awan, F. T., Fogliatto, L., Nikitin, E., Samoilova, O., Habib, A., Foroutanpour, K., Kuptsova-Clarkson, N. & Opat, S., 2022, In: HemaSphere. 6, 10, p. E780

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Patients with CLL have a lower risk of death from COVID-19 in the Omicron era

    Niemann, Carsten, da Cunha-Bang, C., Helleberg, M., Ostrowski, Sisse Rye & Brieghel, C., 2022, In: Blood. 140, 5, p. 445-450 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Cost-effectiveness targeting CLL

    Niemann, Carsten, 2020, In: Blood. 136, 17, p. 1896-1898

    Research output: Contribution to journal › Editorial › Research › peer-review

  18. Published

    BTK inhibitors: safety + efficacy = outcome

    Niemann, Carsten, 2023, In: Blood. 142, 8, p. 679-680 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  19. Published

    Immediate COVID-19 treatment in CLL

    Niemann, Carsten, 2023, In: Blood. 141, 18, p. 2167-2168 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  20. Published

    Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data

    Parviz, M., Brieghel, C., Agius, R. & Niemann, Carsten, 2022, In: Blood advances. 6, 12, p. 3716-3728 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning

    Parviz, M., Agius, R., Rotbain, E. C., Vainer, N., Aarup, K. & Niemann, Carsten, 2024, In: Leukemia and Lymphoma. 65, 4, p. 449-459 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial

    Pettengell, R., Uddin, R., Boumendil, A., Johnson, R., Metzner, B., Martín, A., Romejko-Jarosinska, J., Bence-Bruckler, I., Giri, P., Niemann, Carsten, Robinson, S. P., Kimby, E., Schmitz, N., Dreger, P., Goldstone, A. H. & Montoto, S., 2021, In: Bone Marrow Transplantation. 56, 6, p. 1413-1421 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

    Rawstron, A. C., Kreuzer, K., Soosapilla, A., Spacek, M., Stehlikova, O., Gambell, P., Mciver-brown, N., Villamor, N., Psarra, K., Arroz, M., Milani, R., De La Serna, J., Cedena, M. T., Jaksic, O., Nomdedeu, J., Moreno, C., Rigolin, G. M., Cuneo, A., Johansen, P., Johnsen, H. E. & 13 others, Rosenquist, R., Niemann, Carsten, Kern, W., Westerman, D., Trneny, M., Mulligan, S., Doubek, M., Pospisilova, S., Hillmen, P., Oscier, D., Hallek, M., Ghia, P. & Montserrat, E., 2018, In: Cytometry. Part B: Clinical Cytometry. 94, 1, p. 121-128 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours

    Roen, A., Terrones, C., Bannister, W., Helleberg, M., Andersen, M. A., Niemann, Carsten, Daugaard, G., Specht, Lena, Mocroft, A., Reekie, J. & Lundgren, Jens, 2023, In: Infection. 51, 11 p., 147–157.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    CLL-IPI applied in Binet A CLL: a nationwide cohort study

    Rotbain, E. C., da Cunha-Bang, C., Brieghel, C. & Niemann, Carsten, 2022, In: Blood advances. 6, 21, p. 5698-5701 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  26. Published

    Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia

    Rotbain, E. C., Rostgaard, K., Andersen, M. A., Da Cunha-Bang, C., Niemann, Carsten, Frederiksen, H. & Hjalgrim, Henrik, 2021, In: Clinical Epidemiology. 13, p. 1155-1165 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    The CLL comorbidity index in a population-based cohort: a tool for clinical care and research

    Rotbain, E. C., Gordon, M. J., Vainer, N., Frederiksen, H., Hjalgrim, Henrik, Danilov, A. V. & Niemann, Carsten, 2022, In: Blood advances. 6, 8, p. 2701-2706 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: A danish nationwide population-based study

    Rotbain, E. C., Frederiksen, H., Hjalgrim, Henrik, Rostgaard, K., Egholm, G. J., Zahedi, B., Poulsen, C. B., Enggard, L., Da Cunha-Bang, C. & Niemann, Carsten, 2020, In: Haematologica. 105, 6, p. 1621-1629 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  29. Published

    Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death

    Rotbain, E. C., Niemann, Carsten, Rostgaard, K., da Cunha-Bang, C., Hjalgrim, Henrik & Frederiksen, H., 2021, In: Leukemia. 35, p. 2570–2580

    Research output: Contribution to journal › Journal article › Research › peer-review

  30. Published

    Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia

    Rotbain, E. C., Allmer, C., Rostgaard, K., Andersen, M. A., Vainer, N., da Cunha-Bang, C., Parikh, S. A., Rabe, K. G., Hjalgrim, Henrik, Frederiksen, H., Slager, S. L. & Niemann, Carsten, 2023, In: American Journal of Hematology. 98, 8, p. 1236-1245 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  31. Published

    COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

    Scarfò, L., Chatzikonstantinou, T., Rigolin, G. M., Quaresmini, G., Motta, M., Vitale, C., Garcia-Marco, J. A., Hernández-Rivas, J. Á., Mirás, F., Baile, M., Marquet, J., Niemann, C. U., Reda, G., Munir, T., Gimeno, E., Marchetti, M., Quaglia, F. M., Varettoni, M., Delgado, J., Iyengar, S. & 62 others, Janssens, A., Marasca, R., Ferrari, A., Cuéllar-García, C., Itchaki, G., Špaček, M., De Paoli, L., Laurenti, L., Levin, M. D., Lista, E., Mauro, F. R., Šimkovič, M., Van Der Spek, E., Vandenberghe, E., Trentin, L., Wasik-Szczepanek, E., Ruchlemer, R., Bron, D., De Paolis, M. R., Del Poeta, G., Farina, L., Foglietta, M., Gentile, M., Herishanu, Y., Herold, T., Jaksic, O., Kater, A. P., Kersting, S., Malerba, L., Orsucci, L., Popov, V. M., Sportoletti, P., Yassin, M., Pocali, B., Barna, G., Chiarenza, A., dos Santos, G., Nikitin, E., Andres, M., Dimou, M., Doubek, M., Enrico, A., Hakobyan, Y., Kalashnikova, O., Ortiz Pareja, M., Papaioannou, M., Rossi, D., Shah, N., Shrestha, A., Stanca, O., Stavroyianni, N., Strugov, V., Tam, C., Zdrenghea, M., Coscia, M., Stamatopoulos, K., Rossi, G., Rambaldi, A., Montserrat, E., Foà, R., Cuneo, A. & Ghia, P., 2020, In: Leukemia. 34, 9, p. 2354-2363 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  32. Published

    Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib

    Svanberg, R., Ostrowski, Sisse Rye, Nasserinejad, K., Kersting, S., Dobber, J. A., Mattson, M., Tran, H. T. T., Levin, M., Mous, R., Kater, A. P. & Niemann, Carsten, 2020, In: Leukemia and Lymphoma. 61, 14, p. 3422-3431 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  33. Published

    Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients

    Svanberg, R., MacPherson, C., Zucco, A., Agius, R., Faitova, T., Andersen, M. A., da Cunha-Bang, C., Gjærde, L. K., Møller, M. E. E., Brooks, P. T., Lindegaard, B., Sejdic, A., Harboe, Z. B., Gang, A. O., Hersby, D. S., Brieghel, C., Nielsen, S. D., Podlekareva, D., Hald, A., Bay, J. T. & 6 others, Marquart, Hanne Vibeke Hansen, Lundgren, Jens, Lebech, Anne-Mette, Helleberg, Marie, Niemann, Carsten & Ostrowski, Sisse Rye, 2022, In: Communications Medicine. 2, 15 p., 114.

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    Targeting the tumor microenvironment in chronic lymphocytic leukemia

    Svanberg, R., Janum, S., Patten, P. E. M., Ramsay, A. G. & Niemann, Carsten, 2021, In: Haematologica. 106, 9, p. 2312-2324

    Research output: Contribution to journal › Review › Research › peer-review

  35. Published

    Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials

    Svanberg Teglgaard, R., Marquart, Hanne Vibeke Hansen, Hartling, Hans Jakob Stilling, Bay, Jakob Thaning, da Cunha-Bang, C., Brieghel, C., Faitová, T., Enggaard, L., Kater, A. P., Levin, M. D., Kersting, S., Ostrowski, Sisse Rye & Niemann, Carsten, 2024, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 30, 9, p. 1959-1971 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  36. Published

    Risk of haematologic cancers among individuals tested for Borrelia burgdorferi antibodies, and Borrelia burgdorferi seropositive individuals: a nationwide population-based matched cohort study

    Tetens, M. M., Omland, L. H., Dessau, R., Ellermann-Eriksen, S., Andersen, N. S., Jørgensen, C. S., Østergaard, C., Bodilsen, J., Søgaard, K. K., Bangsborg, Jette Marie, Nielsen, Alex Christian Yde, Møller, J. K., Chen, M., Niemann, Carsten, Lebech, Anne-Mette & Obel, Niels, 2024, In: Clinical Microbiology and Infection. 30, 2, p. 231-239 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia

    Vainer, N., Aarup, K., Andersen, M. A., Wind-Hansen, L., Nielsen, T., Frederiksen, H., Enggaard, L., Poulsen, Christian Bjørn, Niemann, Carsten & Rotbain, E. C., 2023, In: British Journal of Haematology. 201, 5, p. 874-886 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  38. Published

    Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia

    Vojdeman, F. J., Herman, S. E. M., Kirkby, N., Wiestner, A., van T' Veer, M. B., Tjønnfjord, G. E., Itälä-Remes, M. A., Kimby, E., Farooqui, M. Z., Polliack, A., Wu, K. L., Doorduijn, J. K., Alemayehu, W. G., Wittebol, S., Kozak, T., Walewski, J., Abrahamse-Testroote, M. C. J., van Oers, M. H. J., Geisler, C. H. & Niemann, Carsten, 2017, In: Leukemia and Lymphoma. 58, 10, p. 2356-2362

    Research output: Contribution to journal › Journal article › Research › peer-review

  39. Published

    Chronic lymphocytic leukaemia clones are detectable decades before diagnosis

    Vojdeman, F. J., Helby, J., Pedersen, L. B., Brieghel, C., Andersen, M. A., Nordestgaard, Børge, Bojesen, Stig Egil & Niemann, Carsten, 2022, In: British Journal of Haematology. 196, 3, p. 784-787

    Research output: Contribution to journal › Letter › Research › peer-review

  40. Published

    Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations

    Wierda, W. G., Rawstron, A., Cymbalista, F., Badoux, X., Rossi, D., Brown, J. R., Egle, A., Abello, V., Cervera Ceballos, E., Herishanu, Y., Mulligan, S. P., Niemann, C. U., Diong, C. P., Soysal, T., Suzuki, R., Tran, H. T. T., Wu, S. J., Owen, C., Stilgenbauer, S., Ghia, P. & 1 others, Hillmen, P., 2021, In: Leukemia. 35, 11, p. 3059-3072 14 p.

    Research output: Contribution to journal › Review › Research › peer-review

  41. Published

    Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning

    Zucco, Adrian G., Agius, R., Svanberg, R., Moestrup, K. S., Marandi, R. Z., MacPherson, C. R., Lundgren, Jens, Ostrowski, Sisse Rye & Niemann, Carsten, 2022, In: Scientific Reports. 12, 13879.

    Research output: Contribution to journal › Journal article › Research › peer-review

  42. Published

    Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study

    da Cunha-Bang, C., Rostgaard, K., Andersen, M. A., Rotbain, E. C., Grønbæk, Kirsten, Frederiksen, H., Niemann, Carsten & Hjalgrim, Henrik, 2021, In: British Journal of Haematology. 193, 2, p. 339-345

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. Published

    Targeting Bruton's Tyrosine Kinase Across B-Cell Malignancies

    da Cunha-Bang, C. & Niemann, Carsten, 2018, In: Drugs. 78, 16, p. 1653-1663

    Research output: Contribution to journal › Journal article › Research › peer-review

  44. Published

    Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia

    da Cunha-Bang, C., Kirkby, N. S., Friis-Hansen, Lennart Jan & Niemann, Carsten, 2022, In: Leukemia and Lymphoma. 63, 2, p. 503-505

    Research output: Contribution to journal › Letter › Research › peer-review

Previous 1 2 Next

ID: 185059285